Targeted radionuclide therapy in combined-modality regimens
Targeted radionuclide therapy (TRT) is a branch of cancer medicine concerned with the use of radioisotopes, radiolabelled molecules, nanoparticles or microparticles that either naturally accumulate in or are designed to home to tumours. They combine the specificity of molecular and, sometimes, physi...
| Main Authors: | , , , |
|---|---|
| Format: | Journal article |
| Published: |
Elsevier
2017
|